Table 5 Examining moderation of changes in Neuroticism by adverse life event experience and reexperience in the combined sample.
From: Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
Moderator | Between baseline & post | Between baseline and 3-month follow-up | Sample size B | ||
---|---|---|---|---|---|
Timepoint B | Interaction Term B | Timepoint B | Interaction Term B | ||
(A) Adverse life event experienced (full sample) | |||||
Any ALE | − 0.51 | − 0.02 | − 0.41 | − 0.07 | 312 |
Any severe ALE | − 0.54 | 0.02 | − 0.47 | 0.01 | 312 |
Adverse life event index | − 0.49 | − 0.02 | − 0.41 | − 0.02 | 312 |
(B) Adverse life event reexperienced (full sample) | |||||
Any ALE | − 0.45 | − 0.21*** | − 0.39 | − 0.19** | 301 |
Any severe ALE | − 0.50 | − 0.18* | − 0.44 | − 0.14 | 301 |
Reexperiencing index | − 0.47 | − 0.06*** | − 0.42 | − 0.05* | 301 |
(C) Adverse life event reexperienced (only participants who endorsed previous ALE) | |||||
Any ALE (combined sample) | − 0.46 | − 0.18* | − 0.40 | − 0.19* | 259 |
Any ALE (female sample) | − 0.38 | − 0.24* | − 0.37 | − 0.19 | 93 |
Any ALE (male sample) | − 0.49 | − 0.16* | − 0.41 | − 0.19* | 166 |
Any severe ALE (combined sample) | − 0.47 | − 0.17 | − 0.41 | − 0.16 | 170 |
Reexperiencing index (combined sample) | − 0.48 | − 0.05* | − 0.42 | − 0.05* | 259 |